0001701259-20-000001.txt : 20200622 0001701259-20-000001.hdr.sgml : 20200622 20200619205707 ACCESSION NUMBER: 0001701259-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200622 DATE AS OF CHANGE: 20200619 EFFECTIVENESS DATE: 20200622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Phage Therapeutics, Inc. CENTRAL INDEX KEY: 0001701259 IRS NUMBER: 814208730 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-369389 FILM NUMBER: 20977025 BUSINESS ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2408992532 MAIL ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 D 1 primary_doc.xml X0708 D LIVE 0001701259 Adaptive Phage Therapeutics, Inc. 22 FIRSTFIELD ROAD SUITE 125 GAITHERSBURG MD MARYLAND 20878 2408992532 DELAWARE None None Corporation true 2017 Gregory Louis Merril 22 Firstfield Road Suite125 Gaithersburg MD MARYLAND 20878 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2020-06-05 false true false 0 7000000 2825000 4175000 false 12 0 0 0 false Adaptive Phage Therapeutics, Inc. /s/ Gregory Louis Merril Gregory Louis Merril CEO 2020-06-19